The company has also developed other robots like the Angel Suit robotic walking aid designed to assist people with partial paralysis or the elderly with weak muscular strength. There also is Angel Legs M, a robotic medical rehabilitation device used in hospitals for rehabilitation treatment and training.

Angel Legs M is a robot for people with partial paralysis of the lower extremities who have problems walking. Sensors in the robot analyze the user’s movement and, when the need for support is detected, the robot provides appropriate strength. When the user lifts their leg, the weight of the leg is reduced, and when the foot touches the ground, supporting force is provided. The maxon EC 45 flat motor, MILE encoder, and the ESCON Module 50/8 controller implement the robot’s hip joint and knee joint movement and are used to provide smooth and precise supporting strength.

Angel Robotic’s senior researcher Byunghun Na (R&D team) had the following to say about maxon: “When it comes to wearable robots, the weight and size of the motor are very important considerations. The output is important, too, but in order to minimize the load on a user who may have limited strength and to make it easier to get in and out of the suit and to create an acceptable robot design, the motor drive has to be as light and small as possible. Among BLDC motors for various purposes, maxon motors are light and small for their output and highly efficient. They are suitable for robots that are sensitive to size and weight. maxon has different kinds of motor groups and it is easy to choose a motor for the desired output. Since the stability and inner structure are excellent, we are able to increase user confidence in rehabilitation robots.

Given social factors like the growing elderly population, wearable robots are set to become an essential robot technology for all of mankind, not only for the disabled. To achieve this, maxon is taking the lead in continuous product development and technological enhancement in service of a better life for everyone.

 



Source link